Non-viral vectors transform gene delivery for cell therapies
Discover a novel non-viral gene delivery system that could transform cell and gene therapy workflows
Discover a novel non-viral gene delivery system that could transform cell and gene therapy workflows
For the chance to win a $500 Amazon Gift Card (or equivalent currency) cast your vote for the new product that has made the most difference to research
Discover the latest tools and techniques to expand your research capacity with expert-led presentations on protein stability, automated liquid handling, CRISPRi, and more
New transfection reagent is an efficient, stable, and safe delivery system leading to 100% mRNA encapsulation for comparable LNP delivery
For the chance to win a $500 Amazon Gift Card (or equivalent currency) cast your vote for the new product that has made the most difference to research
Find out how unbiased lab product reviews are changing the world of science - and why not get involved yourself?
In this article, Dr. Christian Nievera, senior product manager at Horizon Discovery, discusses how to minimize non-specific effects of siRNA reagents
The kit is ideally suited to NGS library preparation from a low input, patient-derived sample types, such as nasal swabs
Which new products made the most difference to your lab work this year?
This on-demand webinar shows how to simplify your nucleic acid extraction, limit operator-dependent variation, and improve the traceability of your workflows
Science industry comes together online to share knowledge and provide technology solutions for cancer and immunology research
Recognition comes as the publisher launches a series of Virtual Summits to support the science industry through the COVID-19 crisis
Solutions for automation, assay development, high-throughput screening, imaging and more
CRISPR Activation (CRISPRa) and CRISPR Interference (CRISPRi) offer precision, sensitivity and depth of understanding – find out more in this SelectScience expert interview
Expanding CRISPR screening technology to ex vivo primary T cells through a combined lentiviral and electroporation approach
From CRISPR screening to CRISPR/Cas9-edited fusion proteins, we discover the latest technology, news and products in gene editing technology
Functional genomic screening using CRISPR-Cas9 gene editing technology for drug discovery, development and more
Director of the Duke University Functional Genomics Shared Resource shares her thoughts on key screening technologies
Scientists at the National Center for Research on Human Genomics are at the forefront of groundbreaking research to develop new drugs for major diseases
Enleofen Bio and Abzena are working together to develop first-in-class antibody therapeutics for the treatment of fibrotic human diseases
Dr Maria Lopez deciphers microRNA regulation in pain perception. Read on to learn how she successfully uses multiple primary antibodies from the same host species.
Bruker Daltonics and AstraZeneca among those recognized during prestigious ceremony at SLAS2017